IP Library › Assignment 062605/0504
Patent Assignment
Reel/Frame 062605/0504

Assignment of Assignor's Interest

Recorded: 2023-02-06 Pages: 7
Assignors
KENT, JEFFREY D.
Executed: 2022-07-28
LAMOREAUX, BRIAN
Executed: 2022-07-29
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties (2)
Reducing Immunogenicity to Pegloticase
Application: 16/777,646 →
Publication: US 2020/0237881
Reducing Immunogenicity to Pegloticase
Application: 17/955,437 →
Publication: US 2023/0173035
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 31, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC
Reel/Frame 061805/0076 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment. Dec 1, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062073/0930 →
Assignment of Assignor's Interest Feb 6, 2023
From: PETERSON, JEFF
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062604/0437 →
Assignment of Assignor's Interest Feb 6, 2023
From: BOTSON, JOHN
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062604/0497 →